Our IMPACT Clinical Trials Team Partners with API Pharmaceuticals

Life Sciences Innovation

We’ve partnered with Applied Pharmaceutical Innovation to provide companies with greater clinical trial expertise.

Our Integrated Management Platform to Accelerate Clinical Trials (IMPACT) program and Applied Pharmaceutical Innovation (API) have entered into a partnership to expand and fuel the growing world-class research in Alberta and foster innovation through collaboration.

By working together, API and IMPACT will be able to connect life sciences innovators to expertise that matches their needs. IMPACT focuses on helping health-tech or biomedical ventures conduct clinical trials and secure regulatory approvals for medical and digital health technologies.

“This exciting partnership will provide clinical and regulatory support in cutting-edge medical device technology and innovative pharmaceutical drug development. By pooling our resources and expertise, companies and start-ups will benefit from a comprehensive healthcare solution that meets their evolving needs for approvals, market adoption and scaling” Crespo’o Ndiabamoh, Associate Director of IMPACT.

Read the full press release